Inflammation Writes the Fibrogenic Code
Matthew Friedersdorf, PhD, Anna Mae Diehl, MD
Cellular and Molecular Gastroenterology and Hepatology · 2021
doi:10.1016/j.jcmgh.2021.06.012 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Nonalcoholic steatohepatitis (NASH) is an increasingly common chronic liver disease and progression of NASH is associated with increased cirrhosis, liver failure, liver cancer, and mortality. One of the biggest factors associated with NASH progression and liver-related mortality is increased liver fibrosis, highlighting the importance of understanding the mechanisms regulating fibrosis and targeting them for treatment. One of the most potent profibrogenic signals is transforming growth factor beta 1 (TGFB1) and accordingly, increased expression and secretion of this cytokine is associated with NASH progression.
Abstract licence: CC BY-NC-ND
References8
8 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.